Vascular endothelial growth factor receptor 2 (VEGFR2) expression in squamous cell carcinomas of the head and neck

Laryngoscope

Volumn 111, Issue 10, 2001, Pages 1834-1841

  Neuchrist, Csilla ^a,c   Erovic, Boban M ^a   Handisurya, Alessandra ^a   Steiner, Georg E ^a   Rockwell, Patricia ^b   Gedlicka, Claudia ^a   Burian, Martin ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiogenesis; HNSCC; Tumor; Vascular endothelial growth factor receptor 2; VEGFR2

Indexed keywords

CYTOKERATIN; FETAL LIVER KINASE; MESSENGER RNA; MONOCLONAL ANTIBODY; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FROZEN SECTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; VASCULAR ENDOTHELIUM;

EID: 0034790518     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200110000-00031     Document Type: Article

References (42)

1. New perspectives in clinical oncology from angiogenesis research
2. Tumor angiogenesis - A new therapeutic target in gliomas
3. Angiogenesis inhibition drugs in clinical trials
4. Tumor interactions with the vasculature: Angiogenesis and tumor metastasis
5. Tumor angiogenesis: A physiological process or genetically determined?
6. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor
7. The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression
8. Angiogenesis and colonization in the tumor metastatic process: Basic and applied advances
9. Role of vascular endothelial growth factor in the regulation of angiogenesis
10. Vascular endothelial growth factor (VEGF) and its receptors
11. Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia
12. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density
13. Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: An immunohistochemical study
14. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer
15. The related Flt4, Flt1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells
16. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
17. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium
18. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation
19. Vascular endothelial growth factor: Environmental controls and effects in angiogenesis
20. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells
21. Functional expression of vascular endothelial growth factor receptor Flt-1 on squamous cell carcinoma of the head and neck
22. Two functional forms of vascular endothelial growth factor receptor-2/Flk-1 mRNA are expressed in normal rat retina
23. Multiple differentiation pathways of rat mammary stromal cells in vitro: Acquisition of a fibroblast, adipocyte or endothelial phenotype is dependent on hormonal and extracellular matrix stimulation
24. Single-step method of RNA Isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
25. Vascular endothelial growth factor in squamous cell head and neck carcinoma: Expression and prognostic significance
26. Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma
27. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression
28. Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor
29. Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/Flk-1 expression in vascular endothelial cells
30. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells
31. Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor
32. Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells
33. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms
34. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): Correlation with angiogenesis and survival
35. Vascular endothelial growth factor and its receptors, flt-1 and Flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis
36. Vascular endothelial growth factor and its receptors in male fertility
37. Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals
38. Flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors
39. Two molecules related to the VEGF receptor are expressed in early endothelial cells during avian embryonic development
40. KDR receptor: A key marker defining hematopoietic stem cells
41. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry
42. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1